Chemoinformaics analysis of 2,6-DIMETHYLOCT-7-EN-3-OL
Molecular Weight | 156.269 | nRot | 5 |
Heavy Atom Molecular Weight | 136.109 | nRig | 21 |
Exact Molecular Weight | 156.151 | nRing | 0 |
Solubility: LogS | -5.118 | nHRing | 0 |
Solubility: LogP | 6.783 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 30.8379 |
nHD | 1 | BPOL | 20.0641 |
QED | 0.413 |
Synth | 4.861 |
Natural Product Likeliness | 2.894 |
NR-PPAR-gamma | 0.019 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.622 |
Pgp-sub | 0 |
HIA | 0.012 |
CACO-2 | -4.895 |
MDCK | 0.00000831 |
BBB | 0.819 |
PPB | 0.983095 |
VDSS | 1.33 |
FU | 0.0256603 |
CYP1A2-inh | 0.022 |
CYP1A2-sub | 0.49 |
CYP2c19-inh | 0.05 |
CYP2c19-sub | 0.968 |
CYP2c9-inh | 0.107 |
CYP2c9-sub | 0.423 |
CYP2d6-inh | 0.035 |
CYP2d6-sub | 0.875 |
CYP3a4-inh | 0.174 |
CYP3a4-sub | 0.588 |
CL | 16.938 |
T12 | 0.016 |
hERG | 0.028 |
Ames | 0.015 |
ROA | 0.04 |
SkinSen | 0.265 |
Carcinogencity | 0.007 |
EI | 0.036 |
Respiratory | 0.78 |
NR-Aromatase | 0.368 |
Antiviral | No |
Prediction | 0.92895 |